首页> Molecular medicine reports> Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer.

Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Patrick,Lebok

第一单位： Institute of Pathology, University Medical Centre Hamburg‑Eppendorf, D‑20246 Hamburg, Germany.

作者： Patrick,Lebok ^[1] ; Julia,Huber ^[1] ; Eike-Christian,Burandt ^[1] ; Annette,Lebeau ^[1] ; Andreas Holger,Marx ^[1] ; Luigi,Terracciano ^[2] ; Uwe,Heilenkötter ^[3] ; Fritz,Jänicke ^[4] ; Volkmar,Müller ^[4] ; Peter,Paluchowski ^[5] ; Stefan,Geist ^[5] ; Christian,Wilke ^[6] ; Ronald,Simon ^[1] ; Guido,Sauter ^[1] ; Alexander,Quaas ^[7]

作者单位： Institute of Pathology, University Medical Centre Hamburg‑Eppendorf, D‑20246 Hamburg, Germany. ^[1] Institute of Pathology, University Hospital Basel, 4056 Basel, Switzerland. ^[2] Department of Gynaecology, Hospital Itzehoe, D-25524 Itzehoe, Germany. ^[3] Department of Gynaecology, Hospital Pinneberg, D-25421 Pinneberg, Germany. ^[4] Department of Gynaecology, University Medical Centre Hamburg‑Eppendorf, D‑20246 Hamburg, Germany. ^[5] Department of Gynaecology, Hospital Elmshorn, D-25337 Elmshorn, Germany. ^[6] Institute for Pathology, University of Cologne, D‑50937 Cologne, Germany. ^[7]